HOME >> BIOLOGY >> NEWS
Preventing tumor-cell induced bone disease

Bone is a highly hospitable environment for colonization and growth of metastatic tumors, and some of the most common human malignancies, notably breast cancer and prostate cancer, have a strong propensity to produce skeletal metastases. In most cases, tumor cells cause bone disease by co-opting the physiologic mechanisms that normally enhance the production of osteoclasts. In particular, they produce a cytokine called RANK, which activates a vicious cycle of osteolysis and increased osteoclast activation. In this issue of the Journal, Zhang et al show that an endogenous inhibitor of RANK signaling blocks osteoclastic osteolysis and promotes the destruction of human prostate cancer cells that had been introduced into mice.


'"/>

Contact: John Ashkenas
scied@the-jci.org
416-946-7593
Journal of Clinical Investigation
15-May-2001


Page: 1

Related biology news :

1. Preventing cancer: Scientists identify a useful piece of JNK
2. Preventing overload in the brain
3. Preventing rapid extinction of bighorn sheep
4. Jefferson Scientists Find Link Between Learning And Preventing Alzheimers
5. Gene Discovery Paves Way For Preventing Deadly Bacterial Shock
6. Cardiac Clinical Trial Studies Use of Antibiotic In Preventing Heart Attack
7. Drug Therapy Shows Promise In Preventing Hepatitis Infection In Transplant Recipients Who Receive Hepatitis B Positive Livers, Says One Study
8. In New Alzheimers Studies, Lab Tests Show Vitamin E And Other Antioxidants Preventing Brain Cell Death
9. Newly Identified Molecular Mechanism Could Lead To New Approaches For Preventing Heart Attack, Stroke
10. Wistar Scientist To Speak At Toxicology Forum On Effects Of Conjugated Linoleic Acid On Preventing And Reversing Atherosclerosis
11. Suicide Response Gives Colorado State Researchers Important Clues On Preventing Bacterial Invasion In Crops Worldwide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to ... a near term focus on Type 2 diabetes and associated comorbidities. , Justin ... therapeutic areas and classes. As Chief Commercial Officer, Justin will lead Better ...
(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... (PRWEB) , ... August 11, 2020 , ... ... a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... 2021 and 2022. The network is a consortium of academic research centers in ...
(Date:8/7/2020)... (PRWEB) , ... August 06, 2020 , ... ... DNA vaccine industries, announces it has closed on the purchase of greenfield for ... in Conroe, TX and includes over 21 acres in the initial acquisition, with ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has ... different materials for use with CRM, neurostimulation, vascular, and related devices. , ... specific design requirements, performance, and cost criteria; especially where solid wire is limited. ...
Breaking Biology Technology:
Cached News: